A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...

A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...

A recent UCLA study revealed that fewer than one in four eligible adults aged 45-49 underwent colorectal cancer screening ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...

Colon cancer, also known as colorectal cancer, is one of the most frequent and aggressive cancers. According to the WHO, it ...

UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...

For years, healthcare providers have been puzzled by an increase in colorectal cancer cases in young people. Now, new ...

Worldwide, colorectal cancer is the second leading cause of cancer-related mortality and the third most common cancer, with incidence rates increasing among individuals younger than 50 years.1 ...

This study of older, long-term cancer survivors found that chemotherapy was not a driver of late cardiovascular disease (CVD) ...

Artios Pharma is working on a pipeline of oncology assets, led by alnodesertib, currently being tested for second-line ...